POTASSIUM CHANNELS AND EPILEPTOGENESIS
POTASSIUM CHANNELS AND EPILEPTOGENESIS
批准号:
2735506
负责人:
Jong Min Rho
金额:
$10.56万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1997
资助国家:
美国
项目状态:
已结题
起止时间:
1997-07-23 至 2002-06-30
关键词:
aging brain disorder chemotherapy developmental genetics developmental neurobiology electroencephalography epilepsy genetically modified animals hippocampus kainate laboratory mouse neural plasticity neurogenetics neurotoxicology nonhuman therapy evaluation phenobarbital potassium channel protein structure function voltage /patch clamp
中文摘要
该应用程序适用于指导临床科学家的发展
奖(K08)。候选人接受了儿童临床培训
加州大学洛杉矶分校神经病学,然后完成了两年的研究金
美国国立卫生研究院神经药理学(癫痫
研究部门,NINDS)在担任现任教师之前
1994年受聘于华盛顿大学。 长-
候选人的职业目标是研究关系
离子通道和癫痫发生之间的关系,以识别潜在的
具有合理合理性的发育性癫痫新疗法
分子基础,探讨遗传之间的关系
发病机制中的易感性和环境影响
发育性癫痫。 大学医疗中心和
儿童医院基础优势互补
分别是神经科学和临床儿科癫痫学。
实验室空间、设备和专业顾问
在协作的基础上提供给候选人
几个学术部门。 这个环境非常适合
支持和培养候选人的长期专业
目标。 我们选择 mKv1.1 作为我们的实验模型
钾通道单基因小鼠突变体表现出
发育早期自发性癫痫发作。 首先,我们假设
CA 3 中特定钾通道亚基的丢失
海马体区域导致功能改变
锥体神经元的生理特性使得它们
变得过度兴奋并容易过度同步
放电。 其次,我们假设药物治疗
可以改变癫痫的自然病程并可以保护
动物因反复的神经元损伤
癫痫发作。 最后,我们将探讨是否部分表达
正/负小鼠中的 mKv1.1 基因,导致增强
对癫痫发作的易感性,可以通过二次暴露来改变
红藻氨酸(一种强效惊厥剂和神经毒素)
发展。 最初的努力将涉及电生理学
海马切片 CA3 锥体神经元的记录
取自不同年龄的无效突变体;内在和突触
这些细胞的特性以及全细胞钾电流,
将使用细胞外、细胞内和膜片钳进行测量
录音技术。视频脑电图监测(深度
电极)将用于记录癫痫样或癫痫发作
海马体活动和组织化学分析
神经元损伤和/或可塑性将通过常规和
特殊(例如 Timm)污渍。 这些研究的结果可能会导致
更好地了解离子通道在
癫痫的发生,可能有助于解决这个有争议的问题
慢性癫痫发作是否会导致脑损伤,并会提供
进一步研究遗传和
发育中的大脑中的环境相互作用。
英文摘要
This application is for a Mentored Clinical Scientist Development
Award (K08). The candidate obtained clinical training in Child
Neurology at UCLA, and then completed a two-year fellowship in
neuropharmacology at the National Institutes of Health (Epilepsy
Research Branch, NINDS) prior to taking his current faculty
appointment in 1994 at the University of Washington. The long-
term career goal of the candidate is to study the relationship
between ion channels and epileptogenesis, to identify potentially
novel treatments for developmental epilepsies that have a rational
molecular basis, and to explore the relationship between genetic
susceptibility and environmental influence in the pathogenesis of
the developmental epilepsies. The university medical center and
Children's Hospital possess complementary strengths in the basic
neurosciences and clinical pediatric epileptology, respectively.
Laboratory space, equipment, and specialized consultants are
available to the candidate on a collaborative basis provided by
several academic departments. This environment is ideally suited
for supporting and fostering the candidate's long-term professional
goals. We have chosen as our experimental model the mKv1.1
potassiumchannel single gene mouse mutant which exhibits
spontaneous seizures early in development. First, we hypothesize
that loss of a specific potassium channel subunit in the CA 3
region of the hippocampus results in a functional alteration in
physiological properties of pyramidal neurons such that they
became hyperexcitable and prone to excessive synchronization of
discharge. Second, we postulate that pharmacological treatment
can alter the natural course of the epilepsy and may protect the
animal from neuronal injury as a consequence of repeated
seizures. Finally, we will explore whether partial expression of
the mKv1.1 gene in plus/minus mice, resulting in an enhanced
susceptibility to seizures, can be modified by secondary exposure
to kainic acid (a potent convulsant and neurotoxin) early in
development. Initial efforts will involve electrophysiological
recordings from CA3 pyramidal neurons in hippocampal slices
taken from null mutants at different ages; intrinsic and synaptic
properties of these cells, as well as whole-cell potassium currents,
will be measured with extracellular, intracellular and patch-clamp
recording techniques. Video-EEG monitoring (with depth
electrodes) will be employed to document epileptiform or seizure
activity in the hippocampus, and histochemical analysis of
neuronal damage and/or plasticity will be made with routine and
special (e.g., Timm) stains. The results of these studies may lead
to an improved understanding of the role ion channels play in
epileptogenesis, may shed light on the controversial issue of
whether chronic seizures can cause brain damage, and will provide
a framework for further studies examining genetic and
environmental interactions in the developing brain.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
8th Global Symposium on Ketogenic Therapies
-
批准号:10753748
-
项目类别:
-
资助金额:$2.5万
-
财政年份:2023
-
负责人:Jong Min Rho
-
依托单位:
Mechanisms of Seizure Genesis in Human Hypothalamic Hamartomas
-
批准号:7428968
-
项目类别:
-
资助金额:$23.99万
-
财政年份:2008
-
负责人:Jong Min Rho
-
依托单位:
International Symposium on Dietary Therapies for Epilepsy and Other Neurological
-
批准号:7485255
-
项目类别:
-
资助金额:$1.0万
-
财政年份:2008
-
负责人:Jong Min Rho
-
依托单位:
Mechanisms of Seizure Genesis in Human Hypothalamic Hamartomas
-
批准号:7561641
-
项目类别:
-
资助金额:$21.49万
-
财政年份:2008
-
负责人:Jong Min Rho
-
依托单位:
GABAergic Inhibition and the Ketogenic Diet
-
批准号:7216408
-
项目类别:
-
资助金额:$9.14万
-
财政年份:2003
-
负责人:Jong Min Rho
-
依托单位:
GABAergic Inhibition and the Ketogenic Diet
-
批准号:7089078
-
项目类别:
-
资助金额:$9.14万
-
财政年份:2003
-
负责人:Jong Min Rho
-
依托单位:
GABAergic Inhibition and the Ketogenic Diet
-
批准号:6697494
-
项目类别:
-
资助金额:$14.54万
-
财政年份:2003
-
负责人:Jong Min Rho
-
依托单位:
GABAergic Inhibition and the Ketogenic Diet
-
批准号:6556580
-
项目类别:
-
资助金额:$14.54万
-
财政年份:2003
-
负责人:Jong Min Rho
-
依托单位:
GABAergic Inhibition and the Ketogenic Diet
-
批准号:6846232
-
项目类别:
-
资助金额:$14.54万
-
财政年份:2003
-
负责人:Jong Min Rho
-
依托单位:
POTASSIUM CHANNELS AND EPILEPTOGENESIS
-
批准号:6393137
-
项目类别:
-
资助金额:$10.96万
-
财政年份:1997
-
负责人:Jong Min Rho
-
依托单位:
POTASSIUM CHANNELS AND EPILEPTOGENESIS
-
批准号:2891439
-
项目类别:
-
资助金额:$10.56万
-
财政年份:1997
-
负责人:Jong Min Rho
-
依托单位:
POTASSIUM CHANNELS AND EPILEPTOGENESIS
-
批准号:6187567
-
项目类别:
-
资助金额:$2.6万
-
财政年份:1997
-
负责人:Jong Min Rho
-
依托单位:
POTASSIUM CHANNELS AND EPILEPTOGENESIS
-
批准号:6451466
-
项目类别:
-
资助金额:$9.44万
-
财政年份:1997
-
负责人:Jong Min Rho
-
依托单位:
POTASSIUM CHANNELS AND EPILEPTOGENESIS
-
批准号:2373184
-
项目类别:
-
资助金额:$7.67万
-
财政年份:1997
-
负责人:Jong Min Rho
-
依托单位: